Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00841776 · ClinicalTrials.gov registry record · Phase 4
Comparative Antimicrobial Efficacy of Two Topical Acne Therapies for the Treatment of Facial Acne
A Phase 4 study, sponsored by Stiefel, a GSK Company.
- Completed
- Registry status
- Phase 4
- Development phase
- 54
- Enrollment target
NCT00841776 is a Phase 4 study that has completed, run by Stiefel, a GSK Company. The registered enrollment target is 54 participants.
The verdict
NCT00841776, a Phase 4 study, has completed, sponsored by Stiefel, a GSK Company.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 54 participants
- Enrollment target
Study Summary
The purpose of the study is to determine the development of microbial resistance when using one of two topical acne therapies for the treatment of facial acne vulgaris.
Interventions
- DRUG Duac
- DRUG Ziana gel
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 54 participants |
| Start Date | 2007-08 |
| Est. Completion | 2009-01 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00841776
The ClinicalTrials.gov registry entry for NCT00841776 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 54 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Stiefel, a GSK Company, which has 37 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Duac is the first listed.
NCT00841776 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00841776 about?
NCT00841776 is a clinical study titled "Comparative Antimicrobial Efficacy of Two Topical Acne Therapies for the Treatment of Facial Acne". The purpose of the study is to determine the development of microbial resistance when using one of two topical acne therapies for the treatment of facial acne vulgaris.
What is the current status of trial NCT00841776?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 54 participants. The study started on 2007-08. Estimated completion is 2009-01.
What interventions are being tested in trial NCT00841776?
The interventions under investigation include: Duac (DRUG), Ziana gel (DRUG).
Who is sponsoring clinical trial NCT00841776?
This trial is sponsored by Stiefel, a GSK Company, which has 37 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.